Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, […]
Atsena Therapeutics Appoints McDavid Stilwell as Chief Financial Officer GlobeNewswire January 06, 2026 Seasoned biotech executive brings over 25 years of leadership experience across financial strategy and operations, investor relations and business development DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) — Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of
Edible Garden Preliminary Holiday Sales Surge 26.4% Year-Over-Year During Key Time Period Strong Execution, Increased Velocity, Expanded Distribution and Industry-Leading Fulfillment Drives Results GlobeNewswire January 06, 2026 BELVIDERE, NJ, Jan. 06, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA)
Nayax to Showcase New Digital Commerce Products for Specialty and Fashion Retail at NRF 2026 GlobeNewswire January 06, 2026 HERZLIYA, Israel, Jan. 06, 2026 (GLOBE NEWSWIRE) — Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement, payments, and loyalty platform designed to help merchants scale their business, today announced its participation in NRF 2026,
NEW YORK, NY / ACCESS Newswire / January 6, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired SLM Corporation (NASDAQ:SLM) securities. If you suffered a loss on your SLM Corporation investment and would like to explore a potential
(NSE:BIOCON.NS),(BSE Ltd:BIOCON.BO), BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, Jan. 06, 2026 (GLOBE NEWSWIRE) — Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), will introduce three new oncology biosimilars, further strengthening its comprehensive cancer portfolio. The company will also highlight its plans
Biocon Biologics to Expand Biosimilar Oncology Portfolio, Outline Strategic Vision at the 2026 J.P. Morgan Healthcare Conference •New oncology assets to include proposed biosimilars for Trastuzumab/Hyaluronidase combination (Herceptin(R) SC/Herceptin HYLECTA(TM)), Nivolumab (Opdivo(R)) and Pembrolizumab (Keytruda(R)) •Company to outline integration as a wholly owned subsidiary into Biocon Ltd., strengthening its global leadership in biosimilar insulins and
DUBAI, United Arab Emirates, Jan. 06, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) has reported that Halborn Security has finalized an independent audit of its V1 lending and borrowing protocol. The update arrives as the project continues preparing its first protocol release and as its token sale advances through later stages. In early DeFi crypto,
New Crypto Mutuum Finance (MUTM) Reports Finalized Halborn Security Audit as V1 Launch Preparation Builds GlobeNewswire January 06, 2026 DUBAI, United Arab Emirates, Jan. 06, 2026 (GLOBE NEWSWIRE) — Mutuum Finance (MUTM) has reported that Halborn Security has finalized an independent audit of its V1 lending and borrowing protocol. The update arrives as the project
NEW YORK, NY / ACCESS Newswire / January 6, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (NYSE:LRN) securities. If you suffered a loss on your Stride investment and would like to explore a potential recovery